http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104546811-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09 |
filingDate | 2014-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104546811-B |
titleOfInvention | Purposes and pharmaceutical composition of the compound in drug |
abstract | The present invention relates to a kind of compound or its isomers, its pharmaceutically acceptable salt and preparation, include the compound or its isomers, officinal salt and solvate, and pharmaceutically acceptable carrier, the composition of excipient or diluent and compound or composition are used to prevent and/or treat the purposes in the drug of cardiomyopathy and nephrosis. |
priorityDate | 2014-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 198.